Adamantyl-acetamide derivatives as inhibitors of the...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 213/06 (2006.01) A61K 31/44 (2006.01) A61K 31/445 (2006.01) C07D 207/02 (2006.01) C07D 213/24 (2006.01) C07D 213/72 (2006.01)

Patent

CA 2568241

The present invention relates to compounds which are inhibitors of the 11-beta- hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme for the treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, and other diseases and conditions that are mediated by excessive glucocorticoid action.

La présente invention a trait à des composés qui sont inhibiteurs de l'enzyme de type 1 de la 11-bêta-hydroxystéroïde déshydrogénase. La présente invention a également trait à l'utilisation d'inhibiteurs de l'enzyme de type 1 de la 11-bêta-hydroxystéroïde pour le traitement du diabète non insulino-dépendant de type 2, de la résistance à l'insuline, de l'obésité, de troubles lipidiques, du syndrome métabolique, et d'autres maladies et conditions causés par l'intermédiaire d'action glucocorticoïde excessive.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Adamantyl-acetamide derivatives as inhibitors of the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adamantyl-acetamide derivatives as inhibitors of the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adamantyl-acetamide derivatives as inhibitors of the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1442976

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.